Trulicity (dulaglutide) is a brand-name injection prescribed to lower blood sugar levels and reduce the risk of certain cardiovascular problems. It works to treat these conditions by attaching to ...
In an untitled letter dated 19 January 2022, the US Food and Drug Administration’s (FDA) Office of Prescription Drug Promotion (OPDP) cites drugmaker Eli Lilly for a social media post about its type 2 ...
Eli Lilly on Thursday said its blockbuster diabetes drug Mounjaro showed heart health benefits in a late-stage trial directly comparing it to the company's older diabetes treatment, Trulicity.